國立虎尾科技大學 |

The Science and Business of Drug Discovery = Demystifying the Jargon /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	The Science and Business of Drug Discovery/ by Edward D. Zanders.
其他題名:	Demystifying the Jargon /
作者:	Zanders, Edward D.
面頁冊數:	XVII, 402 p. 102 illus., 20 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Theoretical and Computational Chemistry. -
電子資源:	https://doi.org/10.1007/978-3-030-57814-5
ISBN:	9783030578145

The Science and Business of Drug Discovery = Demystifying the Jargon /
Zanders, Edward D.

The Science and Business of Drug DiscoveryDemystifying the Jargon /[electronic resource] :by Edward D. Zanders. - 2nd ed. 2020. - XVII, 402 p. 102 illus., 20 illus. in color.online resource.

Introduction -- PART 1: How Drugs are Discovered and Developed in the Pharmaceutical Industry -- Introduction to Drugs and Drug Targets -- Background to chemistry of small and large molecules -- Laying the foundations- Drug discovery from antiquity to the twenty first century -- Part II-The drug development pipeline – discovery to testing in humans -- Drug discovery pipeline overview -- Target discovery -- Medicinal chemistry -- Biotherapeutics -- Screening for hits -- Process chemistry and formulation -- Preclinical development -- Part III-The drug development pipeline – clinical trials to marketing authorisation -- Clinical trials -- Regulatory affairs and marketing approval -- Diagnostics and personalized medicine -- Putting it All Together: a drug development case history -- Part IV- The Global Pharmaceuticals Business -- Commercial aspects of drug development -- Challenges and responses -- Part V - Professional Interactions with the Drug Discovery Industry.-Professional Interactions with the Drug Discovery Industry: Technology Transfer Executives -- Recruitment Executives -- Pharmaceutical translators and Interpreters.

The Science and Business of Drug Discovery is written for those who want to learn about the biopharmaceutical industry and its products whatever their level of technical knowledge. Its aim is to demystify the jargon used in drug development, but in a way that avoids over simplification and the resulting loss of key information. Each of the twenty chapters is illustrated with figures and tables which clarify some of the more technical points being made. Also included is a drug discovery case history which draws the relevant material together into a single chapter. In recognizing that it is difficult to navigate through the many external resources dealing with drug development, the book has been written to guide the reader towards the most appropriate information sources, including those listed in the two appendices. The following topics are covered: Different types of drugs: from small molecules to stem cells Background to chemistry of small and large molecules Historical background to drug discovery, pharmacology and biotechnology The drug discovery pipeline: from target discovery to marketed medicine Commercial aspects of drug discovery Challenges to the biopharmaceutical industry and its responses Material of specific interest to technology transfer executives, recruiters and pharmaceutical translators .

ISBN: 9783030578145

Standard No.: 10.1007/978-3-030-57814-5doiSubjects--Topical Terms:

670313
Theoretical and Computational Chemistry.

LC Class. No.: RM1-950

Dewey Class. No.: 615

The Science and Business of Drug Discovery = Demystifying the Jargon /
LDR:03853nam a22003975i 4500 001 1022911
003 DE-He213
005 20201109112345.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783030578145 $9 978-3-030-57814-5
024 7 $a 10.1007/978-3-030-57814-5 $2 doi
035 $a 978-3-030-57814-5
050 4 $a RM1-950
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615 $2 23
100 1 $a Zanders, Edward D. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 786169
245 1 4 $a The Science and Business of Drug Discovery $h [electronic resource] : $b Demystifying the Jargon / $c by Edward D. Zanders.
250 $a 2nd ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a XVII, 402 p. 102 illus., 20 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction -- PART 1: How Drugs are Discovered and Developed in the Pharmaceutical Industry -- Introduction to Drugs and Drug Targets -- Background to chemistry of small and large molecules -- Laying the foundations- Drug discovery from antiquity to the twenty first century -- Part II-The drug development pipeline – discovery to testing in humans -- Drug discovery pipeline overview -- Target discovery -- Medicinal chemistry -- Biotherapeutics -- Screening for hits -- Process chemistry and formulation -- Preclinical development -- Part III-The drug development pipeline – clinical trials to marketing authorisation -- Clinical trials -- Regulatory affairs and marketing approval -- Diagnostics and personalized medicine -- Putting it All Together: a drug development case history -- Part IV- The Global Pharmaceuticals Business -- Commercial aspects of drug development -- Challenges and responses -- Part V - Professional Interactions with the Drug Discovery Industry.-Professional Interactions with the Drug Discovery Industry: Technology Transfer Executives -- Recruitment Executives -- Pharmaceutical translators and Interpreters.
520 $a The Science and Business of Drug Discovery is written for those who want to learn about the biopharmaceutical industry and its products whatever their level of technical knowledge. Its aim is to demystify the jargon used in drug development, but in a way that avoids over simplification and the resulting loss of key information. Each of the twenty chapters is illustrated with figures and tables which clarify some of the more technical points being made. Also included is a drug discovery case history which draws the relevant material together into a single chapter. In recognizing that it is difficult to navigate through the many external resources dealing with drug development, the book has been written to guide the reader towards the most appropriate information sources, including those listed in the two appendices. The following topics are covered: Different types of drugs: from small molecules to stem cells Background to chemistry of small and large molecules Historical background to drug discovery, pharmacology and biotechnology The drug discovery pipeline: from target discovery to marketed medicine Commercial aspects of drug discovery Challenges to the biopharmaceutical industry and its responses Material of specific interest to technology transfer executives, recruiters and pharmaceutical translators .
650 2 4 $a Theoretical and Computational Chemistry. $3 670313
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Drug Safety and Pharmacovigilance. $3 1064651
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 0 $a Biotechnology. $3 554955
650 0 $a Chemistry, Physical and theoretical. $3 557299
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Pharmacy. $3 582411
650 0 $a Pharmacology. $3 583819
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030578138
776 0 8 $i Printed edition: $z 9783030578152
776 0 8 $i Printed edition: $z 9783030578169
856 4 0 $u https://doi.org/10.1007/978-3-030-57814-5
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)